Cargando…

A unique presentation of a renal clear cell carcinoma with atypical metastases

INTRODUCTION: Renal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with “inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Staderini, F., Cianchi, F., Badii, B., Skalamera, I., Fiorenza, G., Foppa, C., Qirici, E., Perigli, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446666/
https://www.ncbi.nlm.nih.gov/pubmed/25911241
http://dx.doi.org/10.1016/j.ijscr.2015.03.009
_version_ 1782373476795940864
author Staderini, F.
Cianchi, F.
Badii, B.
Skalamera, I.
Fiorenza, G.
Foppa, C.
Qirici, E.
Perigli, G.
author_facet Staderini, F.
Cianchi, F.
Badii, B.
Skalamera, I.
Fiorenza, G.
Foppa, C.
Qirici, E.
Perigli, G.
author_sort Staderini, F.
collection PubMed
description INTRODUCTION: Renal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with “incidental findings” and those with advanced metastatic disease. PRESENTATION OF CASE: A 70-year-old male with multiple indolent subcutaneous masses underwent colonoscopy after a positive fecal screening test for colorectal carcinoma. A rectal lesion was discovered but biopsy was negative. CT scan revealed advanced renal cancer involving the peritoneal cavity, retroperitoneum and lung. Biopsy of subcutaneous masses confirmed the suspected metastases. The patient underwent surgery (an open left nephrectomy with rectosigmoid resection and metastases debulking) because of a high risk of bowel obstruction and increasing anemia. After three years of multi-targeted therapy and follow-up, the patient is still asymptomatic and in good general condition. DISCUSSION: Treatment of metastatic renal cancer is still controversial even if more than 30% of patients have metastasis at the time of diagnosis. Recently introduced targeted therapies are encouraging but still present problems with side effects and an unlimited period of efficacy. Although there is no consensus, several studies and guidelines consider metastasectomy to be a valid option. CONCLUSION: Recent series highlight surgery as a key-point in the management of advanced renal clear cell carcinoma. Our case demonstrates the validity of a surgical strategy supported by a multidisciplinary approach.
format Online
Article
Text
id pubmed-4446666
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44466662015-05-29 A unique presentation of a renal clear cell carcinoma with atypical metastases Staderini, F. Cianchi, F. Badii, B. Skalamera, I. Fiorenza, G. Foppa, C. Qirici, E. Perigli, G. Int J Surg Case Rep Case Report INTRODUCTION: Renal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with “incidental findings” and those with advanced metastatic disease. PRESENTATION OF CASE: A 70-year-old male with multiple indolent subcutaneous masses underwent colonoscopy after a positive fecal screening test for colorectal carcinoma. A rectal lesion was discovered but biopsy was negative. CT scan revealed advanced renal cancer involving the peritoneal cavity, retroperitoneum and lung. Biopsy of subcutaneous masses confirmed the suspected metastases. The patient underwent surgery (an open left nephrectomy with rectosigmoid resection and metastases debulking) because of a high risk of bowel obstruction and increasing anemia. After three years of multi-targeted therapy and follow-up, the patient is still asymptomatic and in good general condition. DISCUSSION: Treatment of metastatic renal cancer is still controversial even if more than 30% of patients have metastasis at the time of diagnosis. Recently introduced targeted therapies are encouraging but still present problems with side effects and an unlimited period of efficacy. Although there is no consensus, several studies and guidelines consider metastasectomy to be a valid option. CONCLUSION: Recent series highlight surgery as a key-point in the management of advanced renal clear cell carcinoma. Our case demonstrates the validity of a surgical strategy supported by a multidisciplinary approach. Elsevier 2015-04-09 /pmc/articles/PMC4446666/ /pubmed/25911241 http://dx.doi.org/10.1016/j.ijscr.2015.03.009 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Staderini, F.
Cianchi, F.
Badii, B.
Skalamera, I.
Fiorenza, G.
Foppa, C.
Qirici, E.
Perigli, G.
A unique presentation of a renal clear cell carcinoma with atypical metastases
title A unique presentation of a renal clear cell carcinoma with atypical metastases
title_full A unique presentation of a renal clear cell carcinoma with atypical metastases
title_fullStr A unique presentation of a renal clear cell carcinoma with atypical metastases
title_full_unstemmed A unique presentation of a renal clear cell carcinoma with atypical metastases
title_short A unique presentation of a renal clear cell carcinoma with atypical metastases
title_sort unique presentation of a renal clear cell carcinoma with atypical metastases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446666/
https://www.ncbi.nlm.nih.gov/pubmed/25911241
http://dx.doi.org/10.1016/j.ijscr.2015.03.009
work_keys_str_mv AT staderinif auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT cianchif auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT badiib auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT skalamerai auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT fiorenzag auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT foppac auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT qiricie auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT periglig auniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT staderinif uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT cianchif uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT badiib uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT skalamerai uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT fiorenzag uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT foppac uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT qiricie uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases
AT periglig uniquepresentationofarenalclearcellcarcinomawithatypicalmetastases